| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb Co (BMY) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. BMY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 204.7K | $11.55M | - | |
| CFO | 167.4K | $9.45M | - | |
| Dir | 66.1K | $3.73M | - | |
| Dir | 63.2K | $3.57M | - | |
| Dir | 38.9K | $2.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 | Von Autenried Paul | EVP, Chief Information Officer | Sell | 51,134 | $57.18 | $2,923,617.93 | -17.5% | +19.8% | +43.8% | |
| Sep 20, 2021 | Caforio Giovanni59 | Board Chair And CEO | Sell | 25,000 | $60.64 | $1,516,000.00 | -4.9% | +2.8% | +18.9% | |
| Aug 12, 2021 | Elkins David V | EVP, Chief Financial Officer | Sale+OE | 99,691 | $66.95 | $6,674,497.00 | -40.0% | -10.6% | +16.4% | |
| Aug 3, 2021 | Powell Ann64 | EVP, Chief Human Resources | Sell | 23,280 | $68.57 | $1,596,309.60 | -32.8% | -14.6% | +8.6% | |
| Aug 2, 2021 | Caforio Giovanni59 | Chairman And CEO | Sell | 20,000 | $68.58 | $1,371,600.00 | -3.8% | -13.0% | +11.1% | |
| Jul 30, 2021 | Dubow Adam63 | SVP,Chiefcompliance&Ethicsoff. | Sell | 2,466 | $67.90 | $167,441.40 | -15.2% | -15.1% | +12.1% | |
| Jul 30, 2021 | Leung Sandra | EVP, General Counsel | Sell | 29,390 | $68.04 | $1,999,695.60 | -8.0% | -15.1% | +12.1% | |
| Jul 30, 2021 | Von Autenried Paul | EVP, Chief Information Officer | Sell | 25,000 | $68.06 | $1,701,375.00 | -17.9% | -15.1% | +12.1% | |
| Jul 30, 2021 | Vessey Rupert53 | EVP, Research &Early Dev. | Sale+OE | 158,393 | $68.07 | $10,782,153.64 | -65.4% | -15.1% | +12.1% | |
| May 10, 2021 | Eid Joseph | SVP,Head Glob. Medical Affairs | Sell | 1,118 | $65.00 | $72,670.00 | -12.2% | +4.9% | +21.7% |